Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.

NCT00235079 is registered in ClinicalTrials.gov with Azienda Sanitaria Locale 3, Torino as lead sponsor.

NCT NCT00235079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.
Lead sponsor
Azienda Sanitaria Locale 3, Torino
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
December 31, 2011
Enrollment
240 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pericarditis, recurrence